Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-trial pharmacodynamic analysis of T003 in polycythemia vera
jRCT1050250129Completed
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of T003 in polycythemia vera (PV), sponsored by none. Primary endpoint: Estimation of pharmacodynamic effects of T003. Started Oct 2025; status: completed.
02
Drugs
T003
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on jRCT1050250129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050250129.